173 related articles for article (PubMed ID: 7559191)
1. Correlation of in-vitro susceptibility test results with clinical response: a study of azole therapy in AIDS patients.
Rodríguez-Tudela JL; Martínez-Suárez JV; Dronda F; Laguna F; Chaves F; Valencia E
J Antimicrob Chemother; 1995 Jun; 35(6):793-804. PubMed ID: 7559191
[TBL] [Abstract][Full Text] [Related]
2. Comparison of three methods for testing azole susceptibilities of Candida albicans strains isolated sequentially from oral cavities of AIDS patients.
Tortorano AM; Viviani MA; Barchiesi F; Arzeni D; Rigoni AL; Cogliati M; Compagnucci P; Scalise G
J Clin Microbiol; 1998 Jun; 36(6):1578-83. PubMed ID: 9620380
[TBL] [Abstract][Full Text] [Related]
3. Emergence of azole drug resistance in Candida species from HIV-infected patients receiving prolonged fluconazole therapy for oral candidosis.
Johnson EM; Warnock DW; Luker J; Porter SR; Scully C
J Antimicrob Chemother; 1995 Jan; 35(1):103-14. PubMed ID: 7768758
[TBL] [Abstract][Full Text] [Related]
4. Azole resistance among oral Candida species isolates from AIDS patients under ketoconazole exposure.
Milan EP; Burattini MN; Kallás EG; Fischmann O; Costa PR; Colombo AL
Diagn Microbiol Infect Dis; 1998 Nov; 32(3):211-6. PubMed ID: 9884838
[TBL] [Abstract][Full Text] [Related]
5. Emergence of fluconazole-resistant strains of Candida albicans in patients with recurrent oropharyngeal candidosis and human immunodeficiency virus infection.
Ruhnke M; Eigler A; Tennagen I; Geiseler B; Engelmann E; Trautmann M
J Clin Microbiol; 1994 Sep; 32(9):2092-8. PubMed ID: 7814530
[TBL] [Abstract][Full Text] [Related]
6. Cross-sectional study of the susceptibility of Candida isolates to antifungal drugs and in vitro-in vivo correlation in HIV-infected patients.
Chavanet P; Lopez J; Grappin M; Bonnin A; Duong M; Waldner A; Buisson M; Camerlynck P; Portier H
AIDS; 1994 Jul; 8(7):945-50. PubMed ID: 7946104
[TBL] [Abstract][Full Text] [Related]
7. Patterns of in vitro activity of itraconazole and imidazole antifungal agents against Candida albicans with decreased susceptibility to fluconazole from Spain.
Martinez-Suarez JV; Rodriguez-Tudela JL
Antimicrob Agents Chemother; 1995 Jul; 39(7):1512-6. PubMed ID: 7492095
[TBL] [Abstract][Full Text] [Related]
8. Emergence of resistance of Candida albicans to clotrimazole in human immunodeficiency virus-infected children: in vitro and clinical correlations.
Pelletier R; Peter J; Antin C; Gonzalez C; Wood L; Walsh TJ
J Clin Microbiol; 2000 Apr; 38(4):1563-8. PubMed ID: 10747144
[TBL] [Abstract][Full Text] [Related]
9. Fluconazole susceptibility and strain variation of Candida albicans isolates from HIV-infected patients with oropharyngeal candidosis.
Barchiesi F; Arzeni D; Del Prete MS; Sinicco A; Falconi Di Francesco L; Pasticci MB; Lamura L; Nuzzo MM; Burzacchini F; Coppola S; Chiodo F; Scalise G
J Antimicrob Chemother; 1998 May; 41(5):541-8. PubMed ID: 9630407
[TBL] [Abstract][Full Text] [Related]
10. Patterns of fluconazole susceptibility in isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis due to Candida albicans.
Laguna F; Rodríguez-Tudela JL; Martínez-Súarez JV; Polo R; Valencia E; Díaz-Guerra TM; Dronda F; Pulido F
Clin Infect Dis; 1997 Feb; 24(2):124-30. PubMed ID: 9114134
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the risk factors associated with the emergence of azole resistant oral candidosis in the course of HIV infection.
Tumbarello M; Caldarola G; Tacconelli E; Morace G; Posteraro B; Cauda R; Ortona L
J Antimicrob Chemother; 1996 Oct; 38(4):691-9. PubMed ID: 8937963
[TBL] [Abstract][Full Text] [Related]
12. In vitro susceptibility of Candida albicans clinical isolates to eight antifungal agents in Ouagadougou (Burkina Faso).
Zida A; Yacouba A; Bamba S; Sangare I; Sawadogo M; Guiguemde T; Kone S; Traore LK; Ouedraogo-Traore R; Guiguemde RT
J Mycol Med; 2017 Dec; 27(4):469-475. PubMed ID: 28754462
[TBL] [Abstract][Full Text] [Related]
13. Clinically significant azole cross-resistance in Candida isolates from HIV-positive patients with oral candidosis.
Cartledge JD; Midgley J; Gazzard BG
AIDS; 1997 Dec; 11(15):1839-44. PubMed ID: 9412702
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneity in antifungal susceptibility of clones of Candida albicans isolated on single and sequential visits from a HIV-infected southern Chinese cohort.
Samaranayake YH; Samaranayake LP; Tsang PC; Wong KH; Yeung KW
J Oral Pathol Med; 2001 Jul; 30(6):336-46. PubMed ID: 11459319
[TBL] [Abstract][Full Text] [Related]
15. Comparative evaluation of three antifungal susceptibility test methods for Candida albicans isolates and correlation with response to fluconazole therapy.
Ruhnke M; Schmidt-Westhausen A; Engelmann E; Trautmann M
J Clin Microbiol; 1996 Dec; 34(12):3208-11. PubMed ID: 8940474
[TBL] [Abstract][Full Text] [Related]
16. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
17. Iranian HIV/AIDS patients with oropharyngeal candidiasis: identification, prevalence and antifungal susceptibility of Candida species.
Khedri S; Santos ALS; Roudbary M; Hadighi R; Falahati M; Farahyar S; Khoshmirsafa M; Kalantari S
Lett Appl Microbiol; 2018 Oct; 67(4):392-399. PubMed ID: 30019443
[TBL] [Abstract][Full Text] [Related]
18. Defining conditions for microbroth antifungal susceptibility tests: influence of RPMI and RPMI-2% glucose on the selection of endpoint criteria.
Rodriguez-Tudela JL; Martinez-Suárez JV
J Antimicrob Chemother; 1995 Jun; 35(6):739-49. PubMed ID: 7559186
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of a new antifungal triazole, D0870, against Candida albicans isolates from oral cavities of patients infected with human immunodeficiency virus.
Barchiesi F; Colombo AL; McGough DA; Fothergill AW; Rinaldi MG
Antimicrob Agents Chemother; 1994 Nov; 38(11):2553-6. PubMed ID: 7872746
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the E test for fluconazole susceptibility testing of Candida albicans isolates from oropharyngeal candidiasis.
Dannaoui E; Colin S; Pichot J; Piens MA
Eur J Clin Microbiol Infect Dis; 1997 Mar; 16(3):228-32. PubMed ID: 9131326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
